Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study
about
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Sulfatinib, a novel kinase inh ...... : results from a phase I study
@en
type
label
Sulfatinib, a novel kinase inh ...... : results from a phase I study
@en
prefLabel
Sulfatinib, a novel kinase inh ...... : results from a phase I study
@en
P2093
P2860
P356
P1433
P1476
Sulfatinib, a novel kinase inh ...... : results from a phase I study
@en
P2093
Cui Rong Tan
Ji Fang Gong
Jian Ming Xu
P2860
P304
42076-42086
P356
10.18632/ONCOTARGET.14942
P407
P577
2017-02-01T00:00:00Z